Table 1.
Characteristics of patients.
| Group | Case number | Age/years | Sex | Primary pathological changes | Diagnostic methods | Therapy | |||
|---|---|---|---|---|---|---|---|---|---|
| Peripheral | Central | AF | OCT | OCTA | |||||
| A | 1 | 16 | F | VA LD RE SF H |
VA LD RE |
+ | + | + | TTT |
| 2 | 8 | M | VA LD RE SF |
VA LD RE |
+ | + | + | TTT | |
| 3 | 17 | F | VA LD RE SF |
LD RE SF |
+ | + | Poor visual acuity disables OCTA | TTT | |
| 4 | 8 | M | VA LD SF RE |
LD | + | + | + | TTT Cryotherapy |
|
|
| |||||||||
| B | 5 | 11 | M | VA LD |
LD | + | + | + | TTT Cryotherapy |
| 6 | 12 | F | VA LD SF RE |
LD RS |
+ | + | + | TTT Cryotherapy |
|
| 7 | 14 | M | VA LD RE SF |
RE RS EM SF |
+ | + | + | TTT Cryotherapy Barrage laser treatment |
|
| 8 | 12 | M | VA LD RE |
VA LD RS EM |
+ | + | Poor visual acuity artifacts | TTT | |
| 9 | 11 | F | VA RE |
RS EM |
+ | + | + | TTT Barrage laser treatment |
|
F: female; M: male; VA: vascular anomalies; LD: lipid deposits; RE: retinal edema; H: hemorrhage; SF: subretinal fluid; RS: retinal scare; EM: epiretinal membrane.